Skip to content
Riskpilot
← Back to search
Sign in
Sign in
Get full access
Specialty Pharma ApS
APS
Active
Advertising protection
CVR 38476599
Parcelvej 11, 2840
Holte
Business and other management consultancy activities
·
NACE 7020
Est. 2017 · 9 years old
1 employees
www.specialtypharma.dk
Monitor
Share
Denmark
/
Companies
/
Business and other management consultancy activities
/
Specialty Pharma ApS
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
1M
1M
1M
0M
0M
2021: 1M
1M
2021
2022: 1M (0% vs 2021)
1M
0%
2022
2023: 0M (-100% vs 2022)
0M
-100%
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
EBITDA
DKK millions
0M
0M
0M
-1M
-1M
2021: 0M
0M
2021
2022: 0M
0M
2022
2023: 0M
0M
2023
2024: 0M
0M
2024
2025: 0M
0M
2025
Income statement
DKK thousands
Item
2025
2024
2023
2022
2021
Gross profit
217
96
293
1.023
639
Staff expenses
-287
-157
-184
-963
-705
EBITDA
-71
-61
109
60
-65
Depreciation & amort.
-0
-0
-0
-0
-0
EBIT
-71
-61
109
60
-65
Net financials
-0
-2
0
-2
-0
Profit before tax
-71
-63
109
58
-66
Tax
-13
-9
28
17
-22
Net profit
-59
-54
81
41
-44
Balance sheet
DKK thousands
Item
2025
2024
2023
2022
2021
Total assets
86
158
180
116
124
Equity
-18
41
95
14
-27
Long-term debt
0
0
0
0
0
Short-term debt
104
117
86
102
151
Total debt
104
117
86
102
151
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-32,6 %
This company
2021
2025
Equity ratio
-20,8 %
This company
38,2 %
Market median
This company
Market median
154% below market
2021
2025
Return on equity
—
This company
18,4 %
Market median
This company
Market median
2021
2025
Net profit margin (of gross profit)
-27,0 %
This company
2021
2025
Asset turnover (of gross profit)
2,53×
This company
2021
2025
Debt / equity
—
This company
0,62×
Market median
This company
Market median
2021
2025
Annual reports & filings
Annual report 2025
Filed via CVR / Virk · Period 2025-01-01 – 2025-12-31
View
PDF
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
More on Specialty Pharma ApS
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
